DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED

Autres langues Dawnrays Pharmaceutical (Holdings) Limited

Actions

2348

KYG2687M1006

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:09 16/07/2024			Varia. 5j.	Varia. 1 janv.
1,2 ^HKD	-0,83 %		0,00 %	+14,29 %

24/05	Dawnrays Pharmaceutical (Holdings) Limited approuve la déclaration d'un dividende final pour l'exercice clos le 31 décembre 2023	CI
26/03	Dawnrays Pharmaceutical (Holdings) Limited propose un dividende final pour l'exercice clos le 31 décembre 2023, payable le 12 juin 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Dawnrays Pharmaceutical Limited Approves to Declare A Final Dividend for the Year Ended 31 December 2023	24/05
Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024	26/03
Dawnrays' 2023 Profit Falls 9% on Lower Revenue	25/03
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Akeso Unit Buys 35% Stake in Biopharmaceutical Firm from Dawnrays; Akeso Shares Slide 3%	09/02
Dawnrays Pharmaceutical Limited Declares Interim Dividend for the Year Ending December 31, 2023, Payable on October 5, 2023	25/08/23
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Dawnrays Pharmaceutical Limited Announces the National Medical Products Administration Accepts the New Drug Application for Ebronucimab Injection	02/06/23
Dawnrays Pharmaceutical Limited Approves Final Dividend for the Year Ended 31 December 2022	25/05/23
Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 13 June 2023	26/03/23
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2022	26/03/23
Dawnrays Pharmaceutical Unit to Provide $14.4 Million Loan to AD Pharmaceuticals	25/10/22
Dawnrays Pharmaceutical Limited(SEHK:2348) dropped from S&P Global BMI Index	19/09/22
Dawnrays Pharmaceutical Limited Announces Interim Semi-Annual Ordinary Dividend for the Six Months Ended 30 June 2022, Payable on 05 October 2022	26/08/22
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22
Dawnrays Pharmaceutical Limited Declares Final Dividend for the Year Ended December 31, 2021	27/05/22
Dawnrays Pharmaceutical Limited Proposes to Declare Final Dividend for the Year Ended December 31, 2021	21/04/22
Dawnrays Pharmaceutical Limited Announces Final Dividend for the Year Ended 31 December 2021, Payable on 15 June 2022	27/03/22
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2021	27/03/22
Dawnrays Pharma CEO Resigns	17/02/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Dawnrays Pharmaceutical (Holdings) Limited

Actions

2348

KYG2687M1006

Autres langues

Filtres